Skip to content

The effect of Jintiange Capsule on bone quality in elderly male patients with COPD, a prospective cohort study

The effect of Jintiange Capsule on bone quality in elderly male patients with COPD, a prospective cohort study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068032
Enrollment
Unknown
Registered
2023-02-03
Start date
2023-02-03
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Treatment group:Oral Jintiange Capsule + calcitriol + calcium tablets
Control group:Oral calcitriol + calcium tablets

Sponsors

Huadong Hospital Afliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
65 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Male; 2. Age >=65 years old; 3. Voluntary participation, signed informed consent; 4. Can be self-active; 5. The questionnaire can be completed by oneself; 6. Clear diagnosis of pulmonary function COPD.

Exclusion criteria

Exclusion criteria: 1. Serious diseases of the nervous, respiratory, heart, liver and kidney systems or malignant tumors; 2. Secondary osteoporosis caused by various causes; 3. Receiving anti-osteoporosis treatment; 4. Glucocorticoid was used within 3 months.

Design outcomes

Primary

MeasureTime frame
bone mineral density;trabecular bone score;

Secondary

MeasureTime frame
bone metabolism;

Countries

China

Contacts

Public ContactMinmin Chen

Huadong Hospital Afliated to Fudan University

cmm86916@163.com+86 189 1691 4526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026